Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Pulm Pharmacol Ther. 2016 Jan 5;36:46–52. doi: 10.1016/j.pupt.2015.12.004

Figure 3.

Figure 3

Figure 3

Figure 3a. Patient 1 HRCT Before Tacrolimus Treatment

12/2008: HRCT during patient 1’s initial hospitalization demonstrates reticulonodular interstitial abnormalities and patchy ground-glass opacities bilaterally.

Figure 3b. Patient 1 HRCT After Tacrolimus Treatment

10/2009: HRCT 6 months post-tacrolimus initiation reveals that the reticular interstitial opacities are less coarse and ground-glass opacities are decreased.